Publications
- Woolcock JG, Critchley HOD, Munro MG, Broder MS, Fraser IS. Review of the confusion in current and historical terminology and defnitions for disturbances of menstrual bleeding [published online ahead of print February 5 2008]. Fertil Steril 2008.doi:10.1016/j.fertnstert.2007.10.060
- Fraser IS, Critchley HOD, Munro MG, Broder MS. A process designed to lead to international agreement on terminologies and defnitions used to describe abnormalities of menstrual bleeding. Fertil Steril. 2007;87(3):466-476.
- Fraser IS, Critchley HOD, Munro MG, Broder MS. Can we achieve international agreement on terminologies and defnitions used to describe abnormalities of menstrual bleeding? Hum Reprod. 2007;22(3):635-643.
- The Society for the Advancement of Blood Management. The cost of blood: multidisciplinary consensus conference for a standard methodology. Transfus Med Rev. 2005;19(1):66-78.
- Hanley D, Gorelick PB, Elliott WJ, et al. Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: a guideline for primary care physicians from the National Stroke Association work group in recurrent stroke prevention. J Stroke Cerebrovasc Dis. 2004;13(5):196-207.
- Broder M, Oken C, Parker M, Giammona M, Newman J, Harrington C, Rubenstein L. Outpatient Care: A Conceptual Framework And A Form For Structured Implicit Review, Santa Monica, Calif.: RAND, MR-1258, Aug 2001.
- Broder MS, Landow WJ, Goodwin SC, Brook RH, Sherbourne CD, Harris K. An agenda for research into uterine artery embolization: results of an expert panel conference. J Vasc Interv Radiol. 2000;11(4):509-515.
- Broder MS, Kanouse DE, Mittman BS, Bernstein SJ. The appropriateness of recommendations for hysterectomy. Obstet Gynecol. 2000;95(2):199-205.
- Broder MS, Rubenstein LV. Complaints About Quality Of Care: A Structured Implicit Review, Santa Monica, Calif.: RAND, DRU-2638, May 1999.
- Broder MS, Rubenstein LV. Complaints About Quality Of Care: Guidelines For Structured Implicit Review, Santa Monica, Calif.: RAND, DRU-2639, Apr 1999.
- Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population. J Manag Care Pharm. 2008;14(2):176-185.
- Chen K, Chang EY, Summers KH, Obenchain RL, Yu-Isenberg KS, Sun P. Comparison of costs and utilization between users of insulin lispro versus users of regular insulin in a managed care setting. J Manag Care Pharm. 2005;11(5):376-382.
- Ory C, Vanderplas A, Dezii C, Chang E. An economic analysis of healthcare utilization among patients with congestive heart failure compared to those without congestive heart failure within a managed care organization. J Pharmaceut Finance Econ Pol. 2005;14:87-97.
- Yu-Isenberg KS, Vanderplas A, Chang EY, Shah H. Utilization and medical care expenditures in patients with chronic obstructive pulmonary disease: a managed care claims data analysis. Dis Manage Health Outcomes. 2005;13(6):405-412.
- White TJ, Vanderplas A, Change E, Dezii CM, Abrams GD. The costs of non-adherence to oral antihyperglycemic medication in individuals with diabetes mellitus and concomitant diabetes mellitus and cardiovascular disease in a managed care environment. Dis Manage Health Outcomes. 2004;12(3):181-188.
- Stockl K, Vanderplas A, Tafesse E, Chang E. Costs of lower-extremity ulcers among patients with diabetes. Diabetes Care. 2004;27(9):2129-2134.
- Malkin JD, Keeler E, Broder MS, Garber S. Postpartum length of stay and newborn health: a cost-effectiveness analysis. Pediatrics. 2003;111:e316-e322.
- White TJ, Vanderplas A, Ory C, Dezii CM, Chang E. Economic impact of patient adherence with antidepressant therapy within a managed care organization. Dis Manag Health Outcomes. 2003;11(12):817-822.
- Chen KS, Melikian C, Chang E, White TJ. A retrospective analysis of short-term costs and utilization associated with glycemic control among patients diagnosed with type 2 diabetes within a managed care organization [abstract]. Value Health. 2002;5(3):206.
- Wade SW, Magee G, Metz L, Broder MS. Cost-effectiveness of treatments for dysfunctional uterine bleeding. J Reprod Med. 2006;51(7):553-562.
- Keystone E, Burmester GR, Furie R, et al. Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy. Arthritis Rheum. 2008;59(6):785-793.
- Parker WH, Broder MS, Berek JS. Hysterectomy sans oophorectomy: the case for leaving a woman's ovaries alone. Contemporary Ob/Gyn. July 2006.
- Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol. 2005;106(2):219-226.
- Lew KH, Chang EY, Rajagopalan K, Knoth, RL. The effect of medication adherence on health care utilization in bipolar disorder. Manag Care Interface. 2006;19(9):41-46.
- Ory C, Fontes C, Williams SA, Borok G, McDonough K, Chang E. An evaluation of the factors associated with statin dose management and low-density lipoprotein-cholesterol goal attainment. Dis Manag Health Outcomes. 2006;14(1):37-44.
- Broder MS, Spalding J. Treatment patterns for women with new episodes of uterine myomas in an insured population in the US. Current Med Res Opin. 2006;22(1):95-100.
- Gupta JK, Sinha AS, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD005073. DOI: 10.1002/14651858.CD005073.pub2
- Broder MS, Payne-Simon L, Brook RH. Measures of surgical quality: what will patients know by 2005? J Eval Clin Prac. 2005;11(3):209-217.
- Stockl K, Cyprien L, Chang EY. Gastrointestinal bleeding rates among managed care patients newly started on COX-2 inhibitors or nonselective NSAIDs. J Manag Care Pharm. 2005;11(7):550-558.
- Wallis RS, Broder M, Wong J, Lee A, Hoq L. Reactivation of latent granulomatous infections by infliximab. Clin Infect Dis. 2005:41(suppl 3):S194-S198.
- Asch SM, Baker DW, Keesey JW, et al. Does the collaborative model improve care for chronic heart failure? Med Care. 2005;43(7):667-675.
- Morikawa BH, Vanderplas AM, Chang EY, Lew KH. NSAID utilization patterns following market withdrawal of rofecoxib. Formulary. 2005;40:220-226.
- Broder MS, Payne Simon L, Brook RH. Surgical quality: review of Californian measures. Br Med J. 2004;328(7432):152-153.
- Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis. 2004;38(9):1261-1265.
- Broder MS, Bovone S. Improving treatment outcomes with a clinical pathway for hysterectomy and myomectomy. J Reprod Med. 2002;47(12):999-1004.
- White TJ, Chang E, Leslie S, et al. Patient adherence with HMG reductase inhibitor therapy among users of two types of prescription services. J Manag Care Pharm. 2002;8(3):186-191.
- Broder MS, Goodwin S, Chen G, et al. Comparison of long-term outcomes of myomectomy and uterine artery embolization. Obstet Gynecol. 2002;100(5):864-868.
- Melikian C, White TJ, Vanderplas A, Dezii CM, Chang E. Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy. Clin Therapeut. 2002;24(3):460-467.
- Berland GK, Morales LS, Elliott MN, et al. Health information on the Internet: accessibility, quality, and readability in English and Spanish. JAMA. 2001;285(20):2612-2621.
- Broder MS, Kanouse DE, Bernstein SJ. Assessing symptoms before hysterectomy: is the medical record accurate? Am J Obstet Gynecol. 2001(1);185:97-102.
- Berland GK, Morales LS, Elliott MN, et al. Proceed with caution: a report on the quality of health information on the Internet. California HealthCare Foundation, May 2001.
- Malkin JD, Garber S, Broder MS, Keeler E. Infant mortality and early postpartum discharge. Obstet Gynecol. 2000;96(2):183-188.
- Malkin JD, Broder MS, Keeler E. Do longer postpartum stays reduce newborn readmissions? Analysis using instrumental variables. Health Serv Res. 2000;35(5 Pt 2):1071-1091.
- Prendergast ML, Podus D, Chang E. Program factors and treatment outcomes in drug dependence treatment: an examination using meta-analysis. Subst Use Misuse. 2000;35(12-14):1931-1965.
- Broder MS, Oken C, Rubenstein LV. Medicare Beneficiary Alternative Methods Study, Module II. HCFA Report 500-96-P535, October, 1999.
- Broder MS, Harris K, Morton S, Sherbourne C, Brook R. Uterine Artery Embolization: A Systematic Review Of The Literature And Proposal For Research, Santa Monica, Calif.: RAND, MR-1158, Aug 1999.
Books and Book Chapters
- Broder M. The Panic-Free Pregnancy. New York, New York: Perigee Books; 2004.
- Goodwin S, Broder M, Drum D. What Your Doctor May Not Tell You About Fibroids. New York, New York: Warner Books; 2003.
- Broder MS. Gynecologic procedures. In: Hacker N, Moore JG, Gambone JG, eds. Essentials of Gynecology. New York, New York: WB Saunders; 2004.
- Broder M. Benign disorders of the uterine corpus. In: DeCherney AH, Nathan L, eds. Current Obstetric & Gynecologic Diagnosis & Treatment. 9th ed. New York, New York: McGraw-Hill; 2002.
- Broder M. Uterine fibroids. In: Pregler JP, DeCherney AH, eds. Women's Health: Principles and Practice. Hamilton, Ontario, Canada: BC Decker, Inc.; 2002.
Other
- Broder MS, Reissman D. A method for classifying biologics for formulary decision making. Manag Care Interface. 2006;19(4):30-32.
- Furst DE, Wallis R, Broder M, Beenhouwer DO. Tumor necrosis factor antagonists: different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infection. Semin Arthritis Rheum. 2006;36(3):159-167.
- Beenhouwer D, Wallis R, Broder M, Furst DE. Mechanisms of action of tumor necrosis factor antagonists and granulomatous infections. J Rheum. 2004;31(10):1888-1892.
- Broder MS. The active management of labor: is it worth the cost? West J Med. 2000;172(4):243-244.
- Broder MS. Early experiences with a clinical pathway for hysterectomy and myomectomy. J Gynecol Tech. 1998;4:55-59.
